Tacrolimus initial steady state level in post-transplant cyclophosphamide based GvHD prophylaxis regimens

Post-transplant cyclophosphamide (PTCy) combined with tacrolimus (TAC) as graft-versus-host disease (GvHD) prophylaxis post-hematopoietic cell transplantation (HCT) is safe and effective. Optimal serum levels of TAC in this combination remain undetermined. We hypothesized that TAC at initial steady...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Janny M., Yang, Dongyun, Clark, Mary C., Otoukesh, Salman, Cao, Thai, Ali, Haris, Arslan, Shukaib, Aldoss, Ibrahim, Artz, Andrew, Amanam, Idoroenyi, Salhotra, Amandeep, Pullarkat, Vinod, Sandhu, Karamjeet, Stein, Anthony, Marcucci, Guido, Forman, Stephen J., Nakamura, Ryotaro, Al Malki, Monzr M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8825746/
https://www.ncbi.nlm.nih.gov/pubmed/34802049
http://dx.doi.org/10.1038/s41409-021-01528-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8825746/
https://www.ncbi.nlm.nih.gov/pubmed/34802049
http://dx.doi.org/10.1038/s41409-021-01528-y

Ejemplares similares